Comprehensive review of SGLT2 inhibitors’ efficacy through their diuretic mode of action in diabetic patients
SGLT2 inhibitors (SGLT2i) are now the mainstay therapy for both diabetes and heart failure. Post-hoc publications, meta-analysis, and conference presentations of the eight SGLT2i Cardiovascular Outcomes trials (CVOTS) done in diabetic patients constantly echo that this class of drug decreases mortal...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2023-07-01
|
| Серія: | Frontiers in Endocrinology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1174692/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|